§ BIOTECHNOLOGY
USD · Biotechnology

VERA

VERA THERAPEUTICS INC
USDSector · BiotechnologyBeta · 0.88
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
135 increased/new, 72 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B5.87EPS (TTM)-5.54
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Avoro Capital Advisors LLC5.9M2.3%n/a
BlackRock, Inc.5.1M0.0%+5%
Deep Track Capital, LP4.1M2.7%+46%
DEERFIELD MANAGEMENT COMPANY, L.P.3.7M1.8%−8%
Kynam Capital Management, LP3.4M8.4%−1%
State Street3.4M0.0%+26%
◇ AC INTELLIGENCE

Top institutional owners for VERA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER96.8% · 0 holders
OTHER2.1% · 159 holders
DEALER / BANK0.3% · 22 holders
QUALITY / COMPOUNDER0.3% · 18 holders
PASSIVE / INDEX0.3% · 8 holders
TACTICAL / MACRO0.1% · 4 holders
SYSTEMATIC / QUANT0.0% · 7 holders
INCOME / DEFENSIVE0.0% · 12 holders
GROWTH / MOMENTUM0.0% · 1 holder
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for VERA in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES